Business
NuGen M.D. Announces DTC Eligibility Within the United States
TORONTO, ON / ACCESSWIRE / September 12, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD)(OTC...
About this update from Nugen Medical Devices Inc
[{"type":"text","content":"NuGen M.D. Announces DTC Eligibility Within the United StatesTORONTO, ON / ACCESSWIRE / September 12, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD)(OTCQB:NGMDF) (\"NuGen'' or the \"Company\"), a leader in needle-free drug delivery, is pleased to announce that, effective September 9, 2022, its common shares have received Depository Trust Company (\"DTC\") full-service eligibility within the United States. The Company's common shares recently began trading on the OTCQB under the symbol ‘NGMDF' in the United States. The Company's common shares continue to trade on the TSX Venture Exchange in Canada under the symbol \"NGMD\".\"This is an important milestone for Nugen,\" said Michael Wright, CEO of NuGen. \"Building on our recent OTCQB listing, DTC eligibility means that our stock will be even more accessible to trade for a broader range of U.S. investors.\"DTC eligibility allows for book-entry and depository services at the Depository Trust Company for the Company's common shares, which will facilitate electronic clearing and settlement of transfers in the United States.About NuGen Medical DevicesNuGen is an emerging specialty medical device company developing the next generation of needle-free technologies and other innovative medical delivery products. The company's products, which include the InsuJet™ and PetJet™ needle-free injection systems, are designed to improve the lives of millions of people and animals. NuGen continues to receive approval in numerous countries, including Canada. NuGen's products are designed for use in several important fields including, but not limited to, diabetes, veterinary medicine, and vaccines.For More Information visit: www.nugenmd.comTwitter: @NuGenMDLinkedIn: https://www.linkedin.com/company/nugenmd/For further information, please contact:Michael WrightPresident and CEONuGen Medical Devices [email protected] Relations Contact:Kin Communications [email protected](604) 684-6730Twitter: @KinCommNeither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.This news release contains forward-looking information which is subject to a variety of risks and uncertainties and other factors that could cause actual events or resu...